Home › Ovarian Cancer › Illinois › Bloomington
Ovarian Cancer clinical trials in Bloomington, IL
3 studies for Ovarian Cancer are looking for participants at sites in and around Bloomington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- Illinois CancerCare-Bloomington, Bloomington
- Carle BroMenn Medical Center, Normal · 2 mi away
- Carle Cancer Institute Normal, Normal · 2 mi away
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Recruiting
- Carle BroMenn Outpatient Center, Bloomington
- Carle BroMenn Medical Center, Normal · 2 mi away
- Carle Cancer Institute Normal, Normal · 2 mi away
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecruitingPhase 3
- Carle BroMenn Outpatient Center, Bloomington
- Illinois CancerCare-Bloomington, Bloomington
- Carle BroMenn Medical Center, Normal · 2 mi away
- and 1 more
About Ovarian Cancer
Ovarian cancer is a cancerous tumor that forms in the tissues of an ovary. The ovaries are a pair of female reproductive glands that make eggs and female hormones.
More about Ovarian Cancer on MedlinePlus
Ovarian Cancer trials in other cities
- Houston, TX90 studies
- New York City, NY70 studies
- Boston, MA61 studies
- Los Angeles, CA49 studies
- Nashville, TN48 studies
- Arlington, VA46 studies
- Philadelphia, PA44 studies
- Columbus, OH39 studies
- St. Louis, MO37 studies
- Chicago, IL36 studies
- Seattle, WA31 studies
- San Antonio, TX31 studies
Other studies in Bloomington
- Non-Small Cell Lung Cancer11 studies
- Lung Cancer9 studies
- Prostate Cancer7 studies
- Colorectal Cancer7 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Breast Cancer5 studies
- Pancreatic Cancer5 studies
- Melanoma5 studies
- Hypopharyngeal Cancer5 studies
- Laryngeal Cancer5 studies
- Oral Cancer5 studies
- Acute Myeloid Leukemia4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.